New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
about
Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.
P2860
New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
@en
type
label
New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
@en
prefLabel
New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
@en
P2093
P2860
P50
P1476
New pharmacotherapy options for chemotherapy-induced alimentary mucositis
@en
P2093
Hannah R Wardill
Joanne M Bowen
Rachel J Gibson
P2860
P304
P356
10.1517/14712598.2014.874412
P407
P577
2014-01-06T00:00:00Z